In 2011 was created Nestlu00e9 Health Science, which is appeared as Corporate Investor. The venture was found in Europe in Switzerland. The leading representative office of defined Corporate Investor is situated in the Vevey.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Nestlu00e9 Health Science, startups are often financed by Flagship Pioneering, Seventure Partners, Lundbeckfonden Ventures. The meaningful sponsors for the fund in investment in the same round are Seventure Partners, Lundbeckfonden Ventures, Principia SGR. In the next rounds fund is usually obtained by Seventure Partners, Principia SGR, Omnes Capital.
This Nestlu00e9 Health Science works on 9 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2019. The real fund results show that this Corporate Investor is 42 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2016.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ENTEROME Bioscience, Seres Health, Axcella. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Life Science, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Fund Name | Location |
DRL Capital | - |
F+ Ventures | Istanbul, Istanbul, Turkey |
Federated Kaufmann Fund | - |
Hillman Ventures | Pennsylvania, Pittsburgh, United States |
IXOLIT | Austria, Vienna |
k16 Ventures | Berlin, Berlin, Germany |
Mamacrowd | Italy, Lombardy, Milan |
MassAve Global | New York, New York, United States |
Montis Capital | Boulder, Colorado, United States |
OS Fund | Illinois, Park Ridge, United States |
Pale Blue Dot | Malmö, Skane Lan, Sweden |
RSE Ventures | New York, New York, United States |
S-UBG Group | Aachen, Germany, Nordrhein-Westfalen |
SD Skytech | - |
Thorndale Farm | Batavia, New York, United States |
Tsadik Foundation | - |
UK Innovation & Science Seed Fund | Harwell, Oxfordshire, United Kingdom |
Vermillion Capital | Minneapolis, Minnesota, United States |
Wit SoundView Ventures | New York, New York, United States |
Zephyr Acorn | Kenya, Nairobi, Nairobi Area |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ENTEROME | $17M | 20 Apr 2016 | Ile-de-France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ENTEROME | $17M | 20 Apr 2016 | Ile-de-France |